Παρακολούθηση
stavros anevlavis
stavros anevlavis
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα med.duth.gr
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Epidemiology of interstitial lung diseases in Greece
A Karakatsani, D Papakosta, A Rapti, KM Antoniou, M Dimadi, ...
Respiratory medicine 103 (8), 1122-1129, 2009
2972009
Serum biomarkers in interstitial lung diseases
A Tzouvelekis, G Kouliatsis, S Anevlavis, D Bouros
Respiratory research 6, 1-24, 2005
1202005
A prospective study of the diagnostic utility of sputum Gram stain in pneumonia
S Anevlavis, N Petroglou, A Tzavaras, E Maltezos, I Pneumatikos, ...
Journal of Infection 59 (2), 83-89, 2009
1162009
The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome
D Bouros, MG Alexandrakis, KM Antoniou, P Agouridakis, I Pneumatikos, ...
BMC pulmonary medicine 4, 1-9, 2004
1112004
Community acquired bacterial pneumonia
S Anevlavis, D Bouros
Expert opinion on pharmacotherapy 11 (3), 361-374, 2010
1052010
Prognostic factors in patients presenting with pleural effusion revealing malignancy
S Anevlavis, G Kouliatsis, I Sotiriou, MI Koukourakis, K Archontogeorgis, ...
Respiration 87 (4), 311-316, 2014
762014
Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?
A Tzouvelekis, S Anevlavis, D Bouros
Respiratory research 7, 1-13, 2006
762006
Smoking acutely increases plasma ghrelin concentrations
D Bouros, A Tzouvelekis, S Anevlavis, M Doris, S Tryfon, M Froudarakis, ...
Clinical Chemistry 52 (4), 777-778, 2006
632006
Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis: a real-world observational study
A Tzouvelekis, P Ntolios, T Karampitsakos, V Tzilas, S Anevlavis, ...
Pulmonary Pharmacology & Therapeutics 46, 48-53, 2017
582017
Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose‐derived stromal cells‐stromal vascular fraction in idiopathic pulmonary fibrosis
P Ntolios, E Manoloudi, A Tzouvelekis, E Bouros, P Steiropoulos, ...
The Clinical Respiratory Journal 12 (6), 2084-2089, 2018
512018
Recombinant tissue plasminogen activator in the treatment of pleural infections in adults
ME Froudarakis, G Kouliatsis, P Steiropoulos, S Anevlavis, A Pataka, ...
Respiratory medicine 102 (12), 1694-1700, 2008
482008
Efficacy of whole-lung lavage in pulmonary alveolar proteinosis: a multicenter international study of GELF
P Gay, B Wallaert, S Nowak, J Yserbyt, S Anevlavis, C Hermant, A Lovis, ...
Respiration 93 (3), 198-206, 2017
452017
Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4-axis in sarcoidosis patients
A Tzouvelekis, P Ntolios, A Karameris, A Koutsopoulos, P Boglou, ...
BMC research notes 5, 1-9, 2012
382012
Phase 1 trial of lipoplatin and gemcitabine as a second‐line chemotherapy in patients with nonsmall cell lung carcinoma
ME Froudarakis, A Pataka, P Pappas, S Anevlavis, E Argiana, ...
Cancer 113 (10), 2752-2760, 2008
372008
Plasma visfatin levels in severe obstructive sleep apnea—hypopnea syndrome
G Trakada, P Steiropoulos, E Nena, T Gkioka, G Kouliatsis, A Pataka, ...
Sleep and Breathing 13, 349-355, 2009
342009
A polymorphism in the promoter region of the CD86 (B7. 2) gene is associated with systemic sclerosis
AM Abdallah, EA Renzoni, S Anevlavis, AL Lagan, FM Munkonge, ...
International journal of immunogenetics 33 (3), 155-161, 2006
312006
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions
ME Froudarakis, J Plojoux, E Kaspi, S Anevlavis, S Laroumagne, ...
The clinical respiratory journal 12 (3), 1011-1016, 2018
222018
Advances in pleuroscopy
S Anevlavis, ME Froudarakis
The clinical respiratory journal 12 (3), 839-847, 2018
222018
Respiratory muscle strength and lung function in patients undergoing medical thoracoscopy
ME Froudarakis, A Pataka, D Makris, G Kouliatsis, S Anevlavis, I Sotiriou, ...
Respiration 80 (3), 220-227, 2010
212010
Endobronchial metastases from melanoma: a survival analysis
A Chaussende, C Hermant, R Tazi‐Mezalek, N Favrolt, J Hureaux, ...
The Clinical Respiratory Journal 11 (6), 1006-1011, 2017
202017
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20